Pharmafile Logo

Political Intelligence

Political Intelligence is an independent European public affairs consultancy, with offices in London, Brussels, Madrid, Edinburgh and Rome.  We provide our clients with practical public affairs advice that helps them to achieve their business objectives. Our professional and dedicated consultancy service includes political monitoring & intelligence, stakeholder engagement programmes, political and policy research, strategic advice, event management and public affairs training. With our interdisciplinary team we deliver a comprehensive public affairs service throughout the EU.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

69 Wilson Street, London, EC2A 2BB, United Kingdom
+44 (0)20 3397 3300

 Latest Content from PMHub 

Democratizing Brain Health with Digital Assessments

Dr. Pam Ventola, Senior Science Director at Cogstate, shares how the company is working to optimize brain health assessments in rare disease and pediatric clinical trials, and how this can...

Innovative Trials suspends services in Russia in response to Ukraine war

Kate Shaw, Founder & CEO of the leading patient recruitment organisation based in Letchworth (UK), on the current Russia-Ukraine situation.

Nucleus Global launches Chrysalis Medical Communications, the network’s newest agency brand in Europe, with a unifying mission

Press Releases | March 30, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, today launched Chrysalis in Europe with the mission of transforming medical communications together.Stuart Gilbert, Managing Director, said: “Chrysalis’s mission...

Improving diversity in clinical trial patient recruitment

A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many studies find diverse patient recruitment...

Nucleus X Consulting – where patient engagement meets strategic consultancy

Press Releases | March 29, 2022 | Nucleus Global

Nucleus X Consulting consists of an agile team of specialists that combine expertise in all aspects of patient engagement along with strategic consultancy in rare disease and early-phase medical commercialisation.We...

Could I have a word please…?

Just how important is hard hitting copy?

Learning to invest in doctors’ education

Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for...

Top 10 Tips for Running a Successful Virtual Event

As I explored in a recent article previously published on Pharmaphorum, the ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as...

Removing Barriers to Pharmaceutical Accessibility & Affordability Worldwide

Dr. Dhiren Thakker, Founding President and CEO at Med Aditus, shares his insights into how blockchain and other leading-edge technologies can help revolutionize pharmaceutical manufacturing in sub-Saharan Africa and globally....

The Eleven guide to NFTs

Press Releases | March 24, 2022 | 11 London

Non-Fungible Tokens (NFTs) have been making waves in the news lately, specifically around the millions of dollars being exchanged for unique digital art assets. Investors have been queuing up to...